Global NASH Therapeutic Drugs Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by NASH Therapeutic Drugs Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Vitamin E and Pioglitazone
  • 1.4.3 Ocaliva
  • 1.4.4 Elafibranor
  • 1.4.5 Selonsertib and Cenicriviroc
• 1.5 Market by Application
  • 1.5.1 Global NASH Therapeutic Drugs Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital Pharmacy
  • 1.5.3 Online Provider
  • 1.5.4 Retail Pharmacy
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 NASH Therapeutic Drugs Market Perspective (2015-2026)
• 2.2 NASH Therapeutic Drugs Growth Trends by Regions
  • 2.2.1 NASH Therapeutic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 NASH Therapeutic Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 NASH Therapeutic Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 NASH Therapeutic Drugs Market Growth Strategy
  • 2.3.6 Primary Interviews with Key NASH Therapeutic Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top NASH Therapeutic Drugs Players by Market Size
  • 3.1.1 Global Top NASH Therapeutic Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global NASH Therapeutic Drugs Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global NASH Therapeutic Drugs Market Concentration Ratio
  • 3.2.1 Global NASH Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by NASH Therapeutic Drugs Revenue in 2019
• 3.3 NASH Therapeutic Drugs Key Players Head office and Area Served
• 3.4 Key Players NASH Therapeutic Drugs Product Solution and Service
• 3.5 Date of Enter into NASH Therapeutic Drugs Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global NASH Therapeutic Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global NASH Therapeutic Drugs Forecasted Market Size by Type (2021-2026)

5 NASH Therapeutic Drugs Breakdown Data by Application (2015-2026)

• 5.1 Global NASH Therapeutic Drugs Market Size by Application (2015-2020)
• 5.2 Global NASH Therapeutic Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America NASH Therapeutic Drugs Market Size (2015-2020)
• 6.2 NASH Therapeutic Drugs Key Players in North America (2019-2020)
• 6.3 North America NASH Therapeutic Drugs Market Size by Type (2015-2020)
• 6.4 North America NASH Therapeutic Drugs Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe NASH Therapeutic Drugs Market Size (2015-2020)
• 7.2 NASH Therapeutic Drugs Key Players in Europe (2019-2020)
• 7.3 Europe NASH Therapeutic Drugs Market Size by Type (2015-2020)
• 7.4 Europe NASH Therapeutic Drugs Market Size by Application (2015-2020)

8 China

• 8.1 China NASH Therapeutic Drugs Market Size (2015-2020)
• 8.2 NASH Therapeutic Drugs Key Players in China (2019-2020)
• 8.3 China NASH Therapeutic Drugs Market Size by Type (2015-2020)
• 8.4 China NASH Therapeutic Drugs Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan NASH Therapeutic Drugs Market Size (2015-2020)
• 9.2 NASH Therapeutic Drugs Key Players in Japan (2019-2020)
• 9.3 Japan NASH Therapeutic Drugs Market Size by Type (2015-2020)
• 9.4 Japan NASH Therapeutic Drugs Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia NASH Therapeutic Drugs Market Size (2015-2020)
• 10.2 NASH Therapeutic Drugs Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia NASH Therapeutic Drugs Market Size by Type (2015-2020)
• 10.4 Southeast Asia NASH Therapeutic Drugs Market Size by Application (2015-2020)

11 India

• 11.1 India NASH Therapeutic Drugs Market Size (2015-2020)
• 11.2 NASH Therapeutic Drugs Key Players in India (2019-2020)
• 11.3 India NASH Therapeutic Drugs Market Size by Type (2015-2020)
• 11.4 India NASH Therapeutic Drugs Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America NASH Therapeutic Drugs Market Size (2015-2020)
• 12.2 NASH Therapeutic Drugs Key Players in Central & South America (2019-2020)
• 12.3 Central & South America NASH Therapeutic Drugs Market Size by Type (2015-2020)
• 12.4 Central & South America NASH Therapeutic Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Allergan Plc (Tobira)
  • 13.1.1 Allergan Plc (Tobira) Company Details
  • 13.1.2 Allergan Plc (Tobira) Business Overview and Its Total Revenue
  • 13.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction
  • 13.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2015-2020))
  • 13.1.5 Allergan Plc (Tobira) Recent Development
• 13.2 Bristol Myers Squibb
  • 13.2.1 Bristol Myers Squibb Company Details
  • 13.2.2 Bristol Myers Squibb Business Overview and Its Total Revenue
  • 13.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction
  • 13.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2015-2020)
  • 13.2.5 Bristol Myers Squibb Recent Development
• 13.3 Galmed Pharmaceuticals
  • 13.3.1 Galmed Pharmaceuticals Company Details
  • 13.3.2 Galmed Pharmaceuticals Business Overview and Its Total Revenue
  • 13.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction
  • 13.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2015-2020)
  • 13.3.5 Galmed Pharmaceuticals Recent Development
• 13.4 Genfit SA
  • 13.4.1 Genfit SA Company Details
  • 13.4.2 Genfit SA Business Overview and Its Total Revenue
  • 13.4.3 Genfit SA NASH Therapeutic Drugs Introduction
  • 13.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2015-2020)
  • 13.4.5 Genfit SA Recent Development
• 13.5 Gilead Sciences, Inc.
  • 13.5.1 Gilead Sciences, Inc. Company Details
  • 13.5.2 Gilead Sciences, Inc. Business Overview and Its Total Revenue
  • 13.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction
  • 13.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2015-2020)
  • 13.5.5 Gilead Sciences, Inc. Recent Development
• 13.6 Intercept Pharmaceuticals, Inc.
  • 13.6.1 Intercept Pharmaceuticals, Inc. Company Details
  • 13.6.2 Intercept Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  • 13.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction
  • 13.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2015-2020)
  • 13.6.5 Intercept Pharmaceuticals, Inc. Recent Development
• 13.7 Zydus Cadila
  • 13.7.1 Zydus Cadila Company Details
  • 13.7.2 Zydus Cadila Business Overview and Its Total Revenue
  • 13.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction
  • 13.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2015-2020)
  • 13.7.5 Zydus Cadila Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer